SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-20-006943
Filing Date
2020-04-22
Accepted
2020-04-22 17:15:49
Documents
4
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm 10-K/A 114315
2 ex4-12.htm EX-4.12 25306
3 ex31-3.htm EX-31.3 6466
4 ex31-4.htm EX-31.4 6133
  Complete submission text file 0001493152-20-006943.txt   153457
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35570 | Film No.: 20808568
SIC: 2834 Pharmaceutical Preparations